Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros




Base de datos
Intervalo de año de publicación
2.
J Am Acad Dermatol ; 90(4): 807-813, 2024 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-37315800

RESUMEN

Petrolatum, also known as petroleum jelly, is a widely used topical agent, with a variety of uses in dermatology. Despite its popularity, many myths surround this ubiquitous dermatologic staple. This review details the history of petrolatum and how it is manufactured as well as how its biologic properties make it a great moisturizer. Additionally, data on its potential for flammability, allergenicity, and comedogenicity are detailed, dispelling misconceptions about petrolatum use around oxygen and as a cause of acne. The uses and benefits of petrolatum in dermatology are wide-ranging-a patch test instrument, a vehicle for medicated ointments, and a wound care essential. Given its ubiquitous presence, it is important for dermatologists to understand the history, safety profile, and myths surrounding this humble skincare staple.


Asunto(s)
Alérgenos , Vaselina , Humanos , Vaselina/uso terapéutico , Pomadas , Alérgenos/efectos adversos , Pruebas del Parche
3.
J Enzyme Inhib Med Chem ; 23(4): 549-55, 2008 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-18608778

RESUMEN

Butyric acid and trichostatin A (TSA) are anti-cancer compounds that cause the upregulation of genes involved in differentiation and cell cycle regulation by inhibiting histone deacetylase (HDAC) activity. In this study we have synthesized and evaluated compounds that combine the bioavailability of short-chain fatty acids, like butyric acid, with the bidentate binding ability of TSA. A series of analogs were made to examine the effects of chain length, simple aromatic cap groups, and substituted hydroxamates on the compounds' ability to inhibit rat-liver HDAC using a fluorometric assay. In keeping with previous structure-activity relationships, the most effective inhibitors consisted of longer chains and hydroxamic acid groups. It was found that 5-phenylvaleric hydroxamic acid and 4-benzoylbutyric hydroxamic acid were the most potent inhibitors with IC50's of 5 microM and 133 microM respectively.


Asunto(s)
Inhibidores Enzimáticos/química , Ácidos Grasos/química , Inhibidores de Histona Desacetilasas , Ácidos Hidroxámicos/química , Animales , Inhibidores Enzimáticos/síntesis química , Inhibidores Enzimáticos/farmacología , Ácidos Grasos/síntesis química , Ácidos Grasos/farmacología , Histona Desacetilasas/metabolismo , Ácidos Hidroxámicos/síntesis química , Ácidos Hidroxámicos/farmacología , Concentración 50 Inhibidora , Ratas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA